CD44 and neoplasm: The association of siRNA with both chitosan polycation and hyaluronic acid polyanion is an effective strategy to overcome these problems, where chitosan ensures a strengthened siRNA binding and promotes endosomal escape, while the hyaluronic acid provides stability, low protein adsorption, and an inherent capacity to target liver and CD44 overexpressing tumours [34,167].